There’s a Black Market for Eli Lilly’s Unapproved GLP-1 Drug. Here’s Why That’s Bullish
Key PointsEli Lilly's unapproved retatrutide is already popular, as evidenced by the black market for it.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.